News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
242 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
1 (252)
2 (183)
3 (155)
4 (168)
5 (197)
8 (242)
9 (206)
10 (139)
11 (156)
12 (132)
15 (169)
16 (170)
17 (165)
18 (176)
19 (125)
22 (163)
23 (114)
24 (65)
29 (72)
30 (72)
31 (50)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
29
30
31
Drug Development
Bristol-Myers Squibb Company Release: Opdivo (nivolumab) Demonstrates High Overall Response Rate Of 87% for Treatment Of Relapsed Or Refractory Hodgkin Lymphoma
December 8, 2014
·
8 min read
Pharm Country
ContraFect Corporation To Present At The Oppenheimer 25th Annual Healthcare Conference
December 8, 2014
·
3 min read
Business
Nutra Pharma Corp. Letter To Shareholders
December 8, 2014
·
3 min read
Deals
Edwards Lifesciences Grabs Option To Buy CardioKinetix Inc. In $50 Million Financing Deal
December 8, 2014
·
3 min read
Drug Development
Nordic Nanovector Presented Phase I Study Data Reporting Promising Clinical Activity In Patients With Relapsed Non-Hodgkin Lymphoma At American Society of Hematology
December 8, 2014
·
3 min read
Drug Development
ERYtech Pharma Reports Additional Positive Phase 3 Results From Clinical Study With ERY-ASP/GRASPA® In Acute Lymphoblastic Leukemia
December 8, 2014
·
10 min read
Business
NeuroVive Pharmaceutical AB Employs a Clinical Trial Manager
December 8, 2014
·
1 min read
Drug Development
Celgene Release: New Data From Luspatercept Phase 2 Clinical Trial In Beta-Thalassemia Presented at the 56th American Society of Hematology Annual Meeting and Exposition
December 8, 2014
·
8 min read
Drug Development
Celgene Release: Age, Renal Impairment and Depth of Response Analyses of the First (MM-020/IFM 07-01) Study of Continuous REVLIMID® (Lenalidomide) Plus Low-Dose Dexamethasone In Newly-Diagnosed Multiple Myeloma Presented at American Society of Hematology
December 8, 2014
·
21 min read
Business
NovaBay Pharmaceuticals, Inc. Signs Distribution Agreement With The Biopharm Group
December 8, 2014
·
1 min read
Previous
15 of 25
Next
